Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 101–200 of 911
Histone Deacetylation Is Involved in the Transcriptional Repression of hTERT in Normal Human Cells
Cong, Y.-S., & Bacchetti, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000637200 · Cited by 151
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis
Dorer, D. E., & Nettelbeck, D. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.013 · Cited by 163
Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC
Khattar, E., & Tergaonkar, V. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00001 · Cited by 158
Wang, B., Xiong, Q., Shi, Q., Tan, D., Le, X., & Xie, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1014>3.0.co;2-u · Cited by 55
Jiang, F., Bao, J., Li, P., Nicosia, S. V., & Bai, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410395200 · Cited by 152
Simonsson, T., Pribylova, M., & Vorlíčková, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3783 · Cited by 151
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
Bornkamm, G. W., Berens, C., Kuklik-Roos, C., BÉCHET, J.-M., Laux, G., Bachl, J., Korndoerfer, M., Schlee, M., Hölzel, M., Anastassia, M., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni137 · Cited by 195
Oh, S., Song, Y., Yim, J., & Kim, T. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37473 · Cited by 148
Maida, Y., Kyo, S., Kanaya, T., Wang, Z., Yatabe, N., Tanaka, M., Nakamura, M., Ohmichi, M., Gotoh, N., Murakami, S., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205509 · Cited by 161
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 160
Capello, D., Rossi, D., & Gaïdano, G. (2005) · Hematological Oncology · doi:10.1002/hon.751 · Cited by 154
Freyer, M. W., Buscaglia, R., Kaplan, K. A., Cashman, D. J., Hurley, L. H., & Lewis, E. A. S. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.097246 · Cited by 146
Telomerase activation, cellular immortalization and cancer
Hahn, W. C., & Meyerson, M. (2001) · Annals of Medicine · doi:10.3109/07853890109002067 · Cited by 142
Telomeres and Telomerase in Aging, Regeneration and Cancer
Djojosubroto, M. W., Choi, Y. S., Lee, H.-W., & Rudolph, K. L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13723-x · Cited by 147
Targeting c-Myc as a novel approach for hepatocellular carcinoma
Lin, C.-P., Liu, C.-R., Lee, C.-N., Chan, T., & Liu, H. E. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i1.16 · Cited by 145
McMurray, H. R., & McCance, D. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9852-9861.2003 · Cited by 143
CTCF binds the proximal exonic region of hTERT and inhibits its transcription
Renaud, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki989 · Cited by 138
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Patel, P. L., Suram, A., Mirani, N., Bischof, O., & Herbig, U. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602379113 · Cited by 142
“c-Myc transactivates hTERT expression by binding to E-boxes in the promoter region of the hTERT gene (33, 34).”
BackgroundKang, H. J., Choi, Y. S., Hong, S.-B., Kim, K.-W., Woo, R.-S., Won, S. J., Kim, E. J., Jeon, H. K., Jo, S.-Y., Kim, T. K., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4082-03.2004 · Cited by 138
Overexpression of MYC causes p53 -dependent G 2 arrest of normal fibroblasts
Felsher, D. W., Zetterberg, A., Zhu, J., Tlsty, T., & Bishop, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190327097 · Cited by 137
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Tsurimoto, T., Yoshikawa, H., Iguchi-Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10477 · Cited by 129
The mutational landscape of hepatocellular carcinoma
Lee, J. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.3.220 · Cited by 146
HIF-1-mediated activation of telomerase in cervical cancer cells
Yatabe, N., Kyo, S., Maida, Y., Nishi, H., Nakamura, M., Kanaya, T., Tanaka, M., Isaka, K., Ogawa, S., & Inoue, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207460 · Cited by 132
Telomere biology in mammalian germ cells and during development
Bekaert, S., Derradji, H., & Baatout, S. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.06.023 · Cited by 146
Bmi-1: At the crossroads of physiological and pathological biology
Bhattacharya, R., Mustafi, S. B., Street, M., Dey, A., & Dwivedi, S. K. D. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.04.001 · Cited by 143
Masuda, A., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205566 · Cited by 145
Telomerase levels control the lifespan of human T lymphocytes
Röth, A., Yssel, H., Pène, J., Chavez, E. A., Schertzer, M., Lansdorp, P. M., Spits, H., & Luiten, R. M. (2003) · Blood · doi:10.1182/blood-2002-07-2015 · Cited by 135
Seimiya, H., Oh‐hara, T., Suzuki, T., Naasani, I., Shimazaki, T., Tsuchiya, K., & Tsuruo, T. (2002) · PubMed · Cited by 161
Risky immortalization by telomerase
Wang, J., Hannon, G. J., & Beach, D. (2000) · Nature · doi:10.1038/35015674 · Cited by 138
Armstrong, L., Lako, M., Lincoln, J., Cairns, P. M., & Hole, N. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00423-8 · Cited by 151
Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells
Sinha-Datta, U., Horikawa, I., Michishita, E., Datta, A., Sigler-Nicot, J. C., Brown, M., Kazanji, M., Barrett, J. C., & Nicot, C. (2004) · Blood · doi:10.1182/blood-2003-12-4251 · Cited by 126
Arsenic inhibition of telomerase transcription leads to genetic instability
Chou, W.-C., Hawkins, A. L., Barrett, J. F., Griffin, C. A., & Dang, C. V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14064 · Cited by 126
Telomeres and telomerase in prostate cancer development and therapy
Graham, M. K., & Meeker, A. K. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.104 · Cited by 144
Li, H., Xu, D., Li, J., Berndt, M. C., & Liu, J.-P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602381200 · Cited by 124
c-MYC apoptotic function is mediated by NRF-1 target genes
Morrish, F., Giedt, C., & Hockenbery, D. (2003) · Genes & Development · doi:10.1101/gad.1032503 · Cited by 123
Genetic and epigenetic modulation of telomerase activity in development and disease
Liu, L., Lai, S. R., Andrews, L. G., & Tollefsbol, T. O. (2004) · Gene · doi:10.1016/j.gene.2004.06.011 · Cited by 137
Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes
Scian, M. J., Stagliano, K. E., Deb, D., Ellis, M. A., Carchman, E. H., Das, A., Valerie, K. C., Deb, S. P., & Deb, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207553 · Cited by 125
The RNA Subunit of Telomerase Is Encoded by Marek's Disease Virus
Fragnet, L., Blasco, M. A., Klapper, W., & Rasschaert, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5985-5996.2003 · Cited by 130
On the road to immortality: hTERT upregulation in cancer cells
Janknecht, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00356-4 · Cited by 116
Fujimoto, K., Kyo, S., Takakura, M., Kanaya, T., Kitagawa, Y., Itoh, H., Takahashi, M., & Inoue, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.13.2557 · Cited by 116
Xu, X., Chen, W., Miao, R., Zhou, Y., Wang, Z., Zhang, L., Wan, Y., Dong, Y., Qu, K., & Liu, C. (2015) · Oncotarget · doi:10.18632/oncotarget.2905 · Cited by 110
Novel c‐MYC target genes mediate differential effects on cell proliferation and migration
Cappellen, D., Schlange, T., Bauer, M., Maurer, F., & Hynes, N. E. (2007) · EMBO reports · doi:10.1038/sj.embor.7400849 · Cited by 110
Majumdar, A. S., Hughes, D. E., Lichtsteiner, S., Wang, Z., LEBKOWSKI, J. S., & Vasserot, A. P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301421 · Cited by 128
Yaswen, P., & Stampfer, M. R. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00047-x · Cited by 125
Lin, C.-P., Liu, J.-D., Chow, J.-M., Liu, C.-R., & Eugene Liu, H. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280109424 · Cited by 114
Role of Telomerase in Cell Senescence and Oncogenesis
Urquidi, V., Tarin, D., & Goodison, S. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.65 · Cited by 123
Telomeres and immunological diseases of aging.
Andrews, N. P., Fujii, H., Goronzy, J. J., & Weyand, C. M. (2010) · Gerontology · doi:10.1159/000268620 · Cited by 108
“Activators of hTERT transcription include c-Myc, SP1, USF1/2, Ets, HIF-1, and hALP [”
BackgroundHuang, Z., Whelan, C., Foley, N. M., Jebb, D., Touzalin, F., PETIT, E. J., Puechmaille, S. J., & Teeling, E. C. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-019-0913-3 · Cited by 112
Telomere Dynamics in Human Cells Reprogrammed to Pluripotency
Suhr, S. T., Chang, E. A., Rodriguez, R. M., Wang, K., Ross, P. J., Beyhan, Z., Murthy, S., & Cibelli, J. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008124 · Cited by 107
Jagadeesh, S., Kyo, S., & Banerjee, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2494 · Cited by 113
Telomerase in Cancer: Function, Regulation, and Clinical Translation
Robinson, N. J., & Schiemann, W. P. (2022) · Cancers · doi:10.3390/cancers14030808 · Cited by 115
Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis
Han, X., Ren, C., Lü, C., Qiao, P., Yang, T., & Yu, Z. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00971-8 · Cited by 107
Non-canonical Roles of Telomerase: Unraveling the Imbroglio
Ségal-Bendirdjian, E., & Géli, V. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00332 · Cited by 113
Zhang, A., Månér, S., Betz, R., Ångström, T., Stendahl, U., Bergman, F., Zetterberg, A., & Wallin, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10627 · Cited by 105
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
Bellon, M., & Nicot, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm269 · Cited by 104
Immortalization of primary human prostate epithelial cells by c-Myc
Gil, J., Kerai, P., Lleonart, M., Bernard, D., Cigudosa, J. C., Peters, G., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-4030 · Cited by 105
From fibroblasts to iPS cells: Induced pluripotency by defined factors
Zhao, R., & Daley, G. Q. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21871 · Cited by 106
Fu, W., Lu, C., & Mattson, M. P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10710.2002 · Cited by 104
Jung, H. M., Phillips, B. L., & Chan, E. K. L. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-80 · Cited by 107
Huynh, D. L., Sharma, N., Singh, A. K., Sodhi, S. S., Zhang, J., Mongre, R. K., Ghosh, M., Kim, N., Park, Y. H., & Jeong, D. K. (2017) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(17)30005-5 · Cited by 111
Guo, Q., Lin, S., You, Q., Gu, H.-Y., Yu, J., Zhao, L., Qi, Q., Liang, F., Tan, Z., & Wang, X. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.046 · Cited by 104
Kumar, M. R., Zhao, X., & Wang, X. W. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-5 · Cited by 114
Wu, R., Ayhan, A., Maeda, D., Kim, K.-R., Clarke, B. A., Shaw, P. H., Chui, M. H., Rosen, B. P., Shih, I., & Wang, T. (2013) · The Journal of Pathology · doi:10.1002/path.4315 · Cited by 108
Biochemical aspects of telomerase function
Harrington, L. A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00701-2 · Cited by 118
Comparison of early passage, senescent and hTERT immortalized endothelial cells
Chang, M. W.-F., Grillari, J., Mayrhofer, C., Fortschegger, K., Allmaier, G. M., Marzban, G., Katinger, H. W. D., & Voglauer, R. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.002 · Cited by 111
Knight, J. S., Cotter, M. A., & Robertson, E. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101890200 · Cited by 108
Cellular lifespan and senescence signaling in embryonic stem cells
Miura, T., Mattson, M. P., & Rao, M. S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00134.x · Cited by 102
Ulaner, G. A., Hoffman, A. R., Otero, J. E., Huang, H., Zhao, Z., Mazumdar, M., Gorlick, R. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20074 · Cited by 115
Cerezo, A., Kalthoff, H., Schuermann, M., Schäfer, B., & Boukamp, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1305 · Cited by 101
Öğretmen, B., Kraveka, J. M., Schady, D. A., Usta, J. A., Hannun, Y. A., & Obeid, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101350200 · Cited by 105
Liu, X., Yuan, H., Fu, B., Disbrow, G. L., Apolinario, T., Tomaić, V., Kelley, M. L., Baker, C. C., Huibregtse, J., & Schlegel, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410343200 · Cited by 99
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Río, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 101
Inactivation of hTERT transcription by Tax
Gabet, A., Mortreux, F., Charneau, P., Riou, P., Dodon, M. D., Wu, Y., Jeang, K., & Wattel, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206468 · Cited by 110
Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review)
Garg, S., Kaul, S. C., & Wadhwa, R. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4203 · Cited by 123
The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay
Cimino-Reale, G. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.7.e35 · Cited by 101
Hypoxia-Inducible Factor-1 Transactivates Transforming Growth Factor-β3 in Trophoblast
Nishi, H., Nakada, T., Hokamura, M., Osakabe, Y., Itokazu, O., Huang, L. E., & Isaka, K. (2004) · Endocrinology · doi:10.1210/en.2003-1639 · Cited by 95
Wang, F., Yin, Y., Ye, X., Liu, K., Zhu, H., Wang, L., Chiourea, M., Okuka, M., Ji, G., Dan, J., et al. (2011) · Cell Research · doi:10.1038/cr.2011.201 · Cited by 97
PEG10 Is a c-MYC Target Gene in Cancer Cells
Li, C.-M., Margolin, A. A., Salas, M. C., Memeo, L., MANSUKHANI, M. M., Hibshoosh, H. H., Szabolcs, M. J., Klinakis, A., & Tycko, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1553 · Cited by 97
Prognostic relevance of altered Fas (CD95)-system in human breast cancer
Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M. A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P. G., Concetti, A., & Venanzi, F. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l · Cited by 105
Human telomerase activity regulation
Wojtyla, A., Machnik, M., & Rubiś, B. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0439-x · Cited by 104
Bouillez, A., Rajabi, H. N., Pitroda, S. P., Jin, C., Alam, M., Kharbanda, A., Tagde, A., Wong, K., & Kufe, D. W. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1804 · Cited by 96
Stress and immunosenescence: The role of telomerase
de Punder, K., Heim, C., Wadhwa, P. D., & Entringer, S. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.019 · Cited by 90
Non-canonical functions of Telomerase Reverse Transcriptase – Impact on redox homeostasis
Rosen, J., Jakobs, P., Ale‐Agha, N., Altschmied, J., & Haendeler, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101543 · Cited by 103
BRCA1 Inhibition of Telomerase Activity in Cultured Cells
Xiong, J., Fan, S., Meng, Q., Schramm, L., Wang, C., Bouzahza, B., Zhou, J., Zafonte, B. T., Goldberg, I. D., Haddad, B. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8668-8690.2003 · Cited by 110
Telomerase: regulation, function and transformation
Dong, C. K., Masutomi, K., & Hahn, W. C. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.12.005 · Cited by 100
TERT biology and function in cancer: beyond immortalisation
Pestana, A., Vinagre, J., Sobrinho-Simões, M. A., & Soares, P. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0195 · Cited by 110
Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands
Deng, J., Yu, P., Zhang, Z., Wang, J., Cai, J., Wu, N., Sun, H., Liang, H., & Yang, F. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.020 · Cited by 95
White, R. E., Groves, I. J., Turro, E., Yee, J., Kremmer, E., & Allday, M. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013979 · Cited by 94
Telomeres, Telomerase and Ageing
Saretzki, G. (2018) · Subcellular Biochemistry · doi:10.1007/978-981-13-2835-0_9 · Cited by 93
Sirt1 deacetylates c-Myc and promotes c-Myc/Max association
Mao, B., Zhao, G., Lv, X., Chen, H., Xue, Z., Yang, B., Liu, D., & Liang, C. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.07.006 · Cited by 97
Robanus‐Maandag, E. C., Bosch, C. A., Kristel, P. M., Hart, A. A., Faneyte, I. F., Nederlof, P. M., Peterse, J. L., & van de Vijver, M. J. (2003) · The Journal of Pathology · doi:10.1002/path.1385 · Cited by 93
Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro
Li, H., Cao, Y., Berndt, M. C., Funder, J. W., & Liu, J. (1999) · Oncogene · doi:10.1038/sj.onc.1203061 · Cited by 102
Chiang, Y.-C., Teng, S., Su, Y., Hsieh, F., & Wu, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212043200 · Cited by 104
Self-citationDown-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol
Eitsuka, T., Nakagawa, K., & Miyazawa, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.029 · Cited by 94
Krüppel-Like Transcription Factor 4 Contributes to Maintenance of Telomerase Activity in Stem Cells
Wong, C., Hou, P.-S., Tseng, S., Chien, C. L., Wu, K.-J., Chen, H., Ho, H., Kyo, S., & Teng, S. (2010) · Stem Cells · doi:10.1002/stem.477 · Cited by 96
Self-citationHuang, S., Wang, C., Yang, R.-C., Chu, C.-J., Wu, H., & Pang, J. S. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.06.005 · Cited by 88
Horikawa, I., Cable, P. L., Mazur, S. J., Appella, E., Afshari, C. A., & Barrett, J. C. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e01-11-0107 · Cited by 88
EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi, A., Higashino, F., Aoyagi, M., Yoshida, K., Itoh, M., Kyo, S., Ohno, T., Taira, T., Ariga, H., Nakajima, K., et al. (2003) · PubMed · Cited by 86
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
Rottmann, S., & Lüscher, B. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_4 · Cited by 99
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.